Investor List:

Top Health & Hospital Services Series B Investors in Boston / New England (187)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Health & Hospital Services investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Andrew Hedin, Partner at Bessemer Venture Partners
Andrew Hedin
Sweet spot: $25.0M
Range: $1M - $250.0M
Investors in Redwood City (CA), Investors in Boston (MA)
Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Consumer Internet (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Series B), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Consumer Internet (Series A), Investors in Digital Health (Series B), Investors in Consumer Internet (Seed), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Boston / New England (Other Lists), Investors in Consumer Internet (Series B), Investors in Health IT (Seed), Investors in Consumer Internet (Series B), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Jeremy Navarro, Investor at General Catalyst
Jeremy Navarro
Sweet spot: $1M
Range: $500K - $2.0M
Investors in Cambridge (MA)
Photo of Gary Swart, General Partner at Polaris Partners
Gary Swart
Polaris Partners·General Partner
Sweet spot: $500K
Range: $300K - $2.0M
Investors in Atherton, Investors in Boston (MA), Investors in San Francisco (CA), Investors in New York (NY)
Investors in Human Capital/HRTech (Series B), Investors in Human Capital/HRTech (Series B), Investors in Human Capital/HRTech (Seed), Investors in Human Capital/HRTech (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Human Capital/HRTech (Series B), Investors in Sales & CRM (Series B), Investors in Sales & CRM (Series B), Investors in Human Capital/HRTech (Seed), Investors in Digital Health (Series A), Investors in Human Capital/HRTech (Series B), Investors in Human Capital/HRTech (Series A), Investors in Sales & CRM (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Sales & CRM (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Sales & CRM (Series A), Investors in Marketplaces (Series B), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Human Capital/HRTech (Series A), Investors in AI (Series B), Investors in Sales & CRM (Seed), Investors in Human Capital/HRTech (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Enterprise (Series B), Investors in Digital Health (Seed), Investors in Marketplaces (Series A), Investors in Human Capital/HRTech (Series A), Investors in Human Capital/HRTech (Seed), Investors in AI (Series A), Investors in Sales & CRM (Series B), Investors in Marketplaces (Seed), Investors in Health IT (Series A), Investors in Sales & CRM (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series A), Investors in AI (Seed), Investors in Health IT (Seed), Investors in Future of Work (Series B), Investors in Enterprise (Series A), Investors in Marketplaces (Series B), Investors in Health & Hospital Services (Seed), Investors in AI (Series B), Investors in Enterprise (Seed), Investors in Sales & CRM (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Sales & CRM (Seed), Investors in Digital Health (Seed), Investors in Sales & CRM (Series A), Investors in Enterprise (Series B), Investors in Sales & CRM (Seed), Investors in Future of Work (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Marketplaces (Series A), Investors in Health IT (Series B), Investors in Marketplaces (Seed), Investors in Future of Work (Seed), Investors in Health & Hospital Services (Series B), Investors in AI (Seed), Investors in Enterprise (Series A), Investors in Health IT (Series B), Investors in Marketplaces (Series B), Investors in Health & Hospital Services (Series A), Investors in Enterprise (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Marketplaces (Series B), Investors in AI (Series B), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Marketplaces (Series A), Investors in Health IT (Seed), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in Marketplaces (Seed), Investors in Marketplaces (Series A), Investors in Enterprise (Series B), Investors in AI (Series A), Investors in AI (Seed), Investors in Marketplaces (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Matthew Evans, Managing Director at Bain Capital
Matthew Evans
Bain Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Enterprise Applications (Series B), Investors in E-commerce (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Enterprise Applications (Series A), Investors in BioTech (Series B), Investors in Enterprise Applications (Seed), Investors in Health IT (Series A), Investors in E-commerce (Series A), Investors in Health & Hospital Services (Series A), Investors in E-commerce (Seed), Investors in BioTech (Seed), Investors in Enterprise (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Insurance (Series B), Investors in Insurance (Series A), Investors in Real Estate/PropTech (Series B), Investors in Enterprise Applications (Series A), Investors in FinTech (Seed), Investors in Enterprise (Series A), Investors in Real Estate/PropTech (Series A), Investors in Web3/Crypto (Series A), Investors in Enterprise (Seed), Investors in Enterprise Applications (Series B), Investors in Insurance (Series B), Investors in Enterprise Applications (Seed), Investors in FinTech (Series B), Investors in Real Estate/PropTech (Seed), Investors in Web3/Crypto (Series B), Investors in Insurance (Seed), Investors in Insurance (Seed), Investors in FinTech (Series A), Investors in Web3/Crypto (Seed), Investors in E-commerce (Series B), Investors in BioTech (Series B), Investors in Real Estate/PropTech (Series B), Investors in Insurance (Series A), Investors in Real Estate/PropTech (Series A), Investors in Real Estate/PropTech (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Web3/Crypto (Series B), Investors in BioTech (Series A), Investors in Web3/Crypto (Series A), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in E-commerce (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in E-commerce (Seed), Investors in FinTech (Series B), Investors in Health IT (Seed), Investors in Enterprise (Series B), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in Boston / New England (Other Lists)
Photo of Michael A. Ewald, Managing Director at Bain Capital
Michael A. Ewald
Bain Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in E-commerce (Series B), Investors in Enterprise Applications (Series B), Investors in Health & Hospital Services (Series B), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Health IT (Series B), Investors in E-commerce (Series A), Investors in BioTech (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in E-commerce (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in Enterprise (Series B), Investors in Health IT (Seed), Investors in Insurance (Series B), Investors in FinTech (Seed), Investors in Insurance (Series A), Investors in Real Estate/PropTech (Series B), Investors in Enterprise (Series A), Investors in Web3/Crypto (Series A), Investors in Real Estate/PropTech (Series A), Investors in Enterprise (Seed), Investors in Enterprise Applications (Series B), Investors in Insurance (Series B), Investors in Real Estate/PropTech (Seed), Investors in Web3/Crypto (Series B), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series A), Investors in Insurance (Seed), Investors in FinTech (Series A), Investors in Insurance (Series A), Investors in Web3/Crypto (Seed), Investors in Real Estate/PropTech (Series B), Investors in BioTech (Series B), Investors in E-commerce (Series B), Investors in Real Estate/PropTech (Series A), Investors in Real Estate/PropTech (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Insurance (Seed), Investors in Web3/Crypto (Series B), Investors in BioTech (Series A), Investors in Web3/Crypto (Series A), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in E-commerce (Series A), Investors in Health & Hospital Services (Series A), Investors in E-commerce (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in FinTech (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in Boston / New England (Other Lists)
Photo of Peter Spring, Managing Director at Bain Capital
Peter Spring
Bain Capital·Managing Director
Sweet spot: $25.0M
Range: $1M - $100.0M
Investors in Boston (MA)
Photo of Ernesto Anguilla, Managing Director at Bain Capital
Ernesto Anguilla
Bain Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Newton (MA)
Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series B), Investors in Web3/Crypto (Series B), Investors in Health & Hospital Services (Series A), Investors in E-commerce (Series B), Investors in Health & Hospital Services (Series B), Investors in Enterprise Applications (Series A), Investors in Real Estate/PropTech (Seed), Investors in E-commerce (Series A), Investors in BioTech (Series B), Investors in E-commerce (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Web3/Crypto (Seed), Investors in BioTech (Seed), Investors in Enterprise Applications (Series B), Investors in Insurance (Series B), Investors in FinTech (Series A), Investors in Insurance (Series B), Investors in Real Estate/PropTech (Series B), Investors in Enterprise Applications (Series A), Investors in Insurance (Series A), Investors in Real Estate/PropTech (Series B), Investors in Insurance (Seed), Investors in Web3/Crypto (Series A), Investors in Real Estate/PropTech (Series A), Investors in Web3/Crypto (Series B), Investors in Enterprise Applications (Seed), Investors in FinTech (Seed), Investors in Insurance (Seed), Investors in BioTech (Series B), Investors in E-commerce (Series B), Investors in Health & Hospital Services (Series B), Investors in Insurance (Series A), Investors in Real Estate/PropTech (Series A), Investors in BioTech (Series A), Investors in Real Estate/PropTech (Seed), Investors in E-commerce (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in Health & Hospital Services (Seed), Investors in Web3/Crypto (Series A), Investors in E-commerce (Seed), Investors in FinTech (Series B), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Boston / New England (Other Lists)
Photo of Max de Groen, Managing Director at Bain Capital
Max de Groen
Bain Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series A), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in Web3/Crypto (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Real Estate/PropTech (Seed), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in FinTech (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Real Estate/PropTech (Series B), Investors in Insurance (Series B), Investors in Insurance (Series B), Investors in Insurance (Series A), Investors in Insurance (Seed), Investors in Real Estate/PropTech (Series B), Investors in Web3/Crypto (Series A), Investors in Enterprise Applications (Seed), Investors in Real Estate/PropTech (Series A), Investors in Insurance (Seed), Investors in BioTech (Series B), Investors in Web3/Crypto (Series B), Investors in Insurance (Series A), Investors in Health & Hospital Services (Series B), Investors in Real Estate/PropTech (Seed), Investors in BioTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Web3/Crypto (Series A), Investors in Web3/Crypto (Seed), Investors in Health & Hospital Services (Seed), Investors in FinTech (Series B), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Boston / New England (Other Lists)